The first total synthesis of moloka'iakitamide (1), a recently reported bromotyrosine alkaloid from Pseudoceratina arabica with oxalamide moiety, was achieved in 7 steps from commercially available tyramine (26% overall).
Notes
Bromotyrosine alkaloids, well known as one of biologically active substances, possess a wide range of biological activities including anti human immunodeficiency virus 1 (HIV-1) activity, 1) anti methicillin-resistant Staphylococcus aureus (MRSA) activity, 2) anti multidrug-resistant Mycobacterium tuberculosis activity, 3) and anti-angiogenic activity. 4) These are also known as therapeutically important G proteincoupled receptors, the histamine H 2 and H 3 receptors 5, 6) and the adrenergic a 1D and a 2A receptors 6) antagonist. Because of these interesting activities, a number of synthetic studies on these alkaloids have been reported. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Moloka'iakitamide (1) 17) has been isolated from the Red Sea sponge Pseudoceratina arabica (Pseudoceratinidae) and shows significant parasympatholytic effects on isolated rabbit heart and jejunum, and weakly antifungal activity, contains one bromotyrosine unit and oxalamide moiety (Fig. 1) . In this paper we present the first total synthesis of moloka'iakitamide (1).
Results
As outlined in Chart 1, retrosynthetic analysis of moloka'iakitamide (1) envisaged an alkylation of brominated tyramine (2) with protected amine derivative (3), followed by an amide coupling between oxamic acid (4).
Our synthesis began with commercially available tyramine (5). Introduction of a bromine atom at 5 was carried out by reported method in 2 steps. 15) Di-brominated phenol (6) was treated with iodide (8) , which was prepared from N-(3-hydroxyproyl)phthalimide (7), 18) in the presence of potassium carbonate (K 2 CO 3 ) and benzyltriethylammonium chloride (BTAC) provided ether (9) in high yields (Chart 2).
After dephthalimidation of 9 with hydrazine monohydrate in ethanol to give amine (10), followed by coupling with oxamic acid (4) using 2-chloro-1,3-dimethylimidazolinium chloride (DMC) as a dehydrating agent, 19) the N-Bocmoloka'iakitamide (11) was afforded in moderate yield. Deprotection of N-Boc function in 11 with acidic condition, and the residue was made alkaline to give moloka'iakitamide (1) (Chart 3). Thus, the first total synthesis of moloka'iakitamide (1) was completed.
The C-NMR data of our synthetic moloka'iakitamide (1) were not in complete accordance with those re-
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Makoto YOSHIDA and Kentaro YAMAGUCHI* ported for natural moloka'iakitamide (1) by Badr et al. 17) On the other hand, moloka'iakitamide trifluoroacetate (1-TFA), which was prepared from 1 and trifluoroacetic acid, were spectroscopically identical with reported data (Table 1) . Thus, the original report of natural moloka'iakitamide (1) by Badr et al., 17) characterized a protonated salt form, such as 1-TFA, and not the free-base 1.
In conclusion, we succeeded in the first total synthesis of moloka'iakitamide (1) from commercially available tyramine as a starting material. The overall yield was 26% for moloka'iakitamide (1) from tyramine (5) in 7 steps.
Experimental
All manipulations were carried out under air atmosphere. IR spectra were recorded on a JASCO FT/IR-6300 spectrophotometer; ATRϭattenuated total reflectance system. NMR spectra were recorded on a JEOL JNM-ECX400 ( 15, 18) Synthesis of Ether (9) A mixture of phenol (6) (410 mg, 1.04 mmol), iodide (8) (325 mg, 1.03 mmol), BTAC (24 mg, 0.105 mmol), and K 2 CO 3 (290 mg, 2.10 mmol) in CH 3 CN (6.0 ml) was stirred at rt for 48 h. The reaction mixture was poured into water, and extracted with AcOEt. The organic layer was washed with water and brine, dried over Na 2 SO 4 , and evaporated. The residue was purified by SiO 2 -column chromatography (eluent: toluene/AcOEtϭ22 : 1) to give 9 as a colorless amorphous (602 mg, quant. 
Synthesis of N-Boc-moloka'iakitamide (11)
To a solution of amine (10) (80 mg, 0.18 mmol), oxamic acid (4) (18 mg, 0.20 mmol), and Et 3 N (0.10 ml, 0.72 mmol) in N,N-dimethylformamide (DMF) (1.5 ml) 2-chloro-1,3-dimethylimidazolinium chloride (DMC, 34 mg, 0.20 mmol) was added, and the mixture was stirred at rt for 2 h. The reaction mixture was poured into water, and extracted with AcOEt. The organic layer was washed with water and brine, dried over Na 2 SO 4 , and evaporated. The residue was purified by SiO 2 -column chromatography (eluent: CHCl 3 /AcOEtϭ7 : 2) to give 11 as a colorless amorphous (56 mg, 61% 
